𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methyl-ccnu, alone and in combination with vincristine, or vincristine and methotrexate, in advanced bronchogenic carcinoma

✍ Scribed by Frederick Richards; M. Robert Cooper; Hyman B. Muss; Douglas R. White; Charles L. Spurr


Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
415 KB
Volume
38
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Combination chemotherapy with methotrexa
✍ M. Clavel; F. Cognetti; P. Dodion; J. Wildiers; R. Rosso; A. Rossi; B. Gignoux; πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 449 KB πŸ‘ 2 views

## For the EORTC Head and Neck Cooperative Group A total of 185 eligible patients with advanced inoperable squamous cell carcinoma of the head and neck were randomized into two groups; the cisplatin, methotrexate, bleomycin, and vincristine (CABO) group received cisplatin (50 mg/m2; day 4), methot

Combination therapy with methotrexate, v
✍ Alvaro Aguayo; Jorge Cortes; Deborah Thomas; Sherry Pierce; Michael Keating; Hag πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 72 KB πŸ‘ 1 views

BACKGROUND. L-asparaginase in combination with methotrexate has synergistic antileukemic activity in a schedule-dependent fashion. A new preparation of L-asparaginase, polyethylene-glycol conjugated (PEG)-asparaginase, is a pharmacologically different formulation of L-asparaginase with distinct prop

Phase II trial of intermediate dose meth
✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Howard Scher; Vaia Vlamis; Gera πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Background: This study was undertaken to determine whether the use of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin as first-line therapy increases the proportion of major responders and overall survival in patients with unresectable or metastatic tra